RxDoctor Payments Data

Andrew Kapsalis, DPM

Podiatrist · Avon, INNPI 1780093765

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $26,175 of the $37,458 with a category attached, or 69.9%. 33 manufacturers reported payments, led by Fusion Orthopedics USA, LLC at 53.9% of the total. Reporting peaked in 2023 at $15,346 and has fallen 88.8% since, to $1,724 in 2025. Among podiatrist clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,458in general payments, 2019–2025

Across 132 payments — averaging $283.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fusion Orthopedics USA, LLC$20K
  • Summ Cott Medical$5K
  • Biopoly LLC$3K
  • Crossroads Orthopedics, LLC$3K
  • Trilliant Surgical LLC.$2K
  • Paragon 28, Inc.$1K
  • plus $3K from 27 others
$36,131in research payments, 2019–2025

Across 12 payments — averaging $3010.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Paragon 28, Inc.$36K

What the payments were for

  • Consulting fees$26,17570%
  • Speaking & faculty fees$5451%
  • Travel & lodging$3,78710%
  • Food & beverage$4,36112%
  • Education$2,5917%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,458 in reported general payments places this provider in the 95th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$112,017
Medicare patients
385
Services billed
1,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl186$1,715
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen162$1,334
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$863
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen104$826
Pregabalin26$515
Methylprednisolone69$456
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav50$395
Ammonium Lactate11$350
Tramadol Hcl49$334
Doxycycline Hyclate38$298
Gabapentin29$230
Ketorolac Tromethamine23$214
Prednisone73$169
Allopurinol18$143
Meloxicam42$115

Paid to pharmacies, not to this prescriber.

Other podiatrist in Avon

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →